Literature DB >> 8898867

Annexins and protein kinases C.

T Dubois1, J P Oudinet, J P Mira, F Russo-Marie.   

Abstract

Annexins and protein kinases C belong to two distinct families of ubiquitous cytoplasmic proteins involved in signal transduction. All annexins share the property of binding calcium and phospholipids in the presence of calcium. Protein kinases C belong to three distinct groups of kinases: cPKCs (conventional PKCs) depend on calcium, diacylglycerol and negatively charged phospholipids for their activity, nPKCs (novel PKCs) depend on diacylglycerol and negatively charged phospholipids and aPKCs (atypical PKCs) only require negatively charged phospholipids. Almost all annexins are both in vitro and in vivo substrates for PKCs except annexin V. All annexins have a putative binding site for PKCs but only annexin V would possess a potential pseudo-substrate site. We propose that annexin V modulates the activity of some cPKCs on their substrates which may be the other annexins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898867     DOI: 10.1016/0167-4889(96)00102-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry.

Authors:  Xing-Dong Xiong; Li-Yan Xu; Zhong-Ying Shen; Wei-Jia Cai; Jian-Min Luo; Ya-Li Han; En-Min Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 2.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

3.  Intracellular modulation of signaling pathways by annexin A6 regulates terminal differentiation of chondrocytes.

Authors:  Takeshi Minashima; William Small; Stephen E Moss; Thorsten Kirsch
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

4.  Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.

Authors:  Shu-Hsiang Liu; Chiao-Ying Lin; Shian-Yang Peng; Yung-Ming Jeng; Hung-Wei Pan; Po-Lin Lai; Chao-Lien Liu; Hey-Chi Hsu
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.

Authors:  F M Brichory; D E Misek; A M Yim; M C Krause; T J Giordano; D G Beer; S M Hanash
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration.

Authors:  T Dubois; J P Mira; D Feliers; E Solito; F Russo-Marie; J P Oudinet
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 7.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

8.  Modulation of paclitaxel resistance by annexin IV in human cancer cell lines.

Authors:  E K Han; S K Tahir; S P Cherian; N Collins; S C Ng
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

9.  Post-translational modifications of Annexin A2 are linked to its association with perinuclear nonpolysomal mRNP complexes.

Authors:  Ingvild Aukrust; Linn Andersen Rosenberg; Mia Madeleine Ankerud; Vibeke Bertelsen; Hanne Hollås; Jaakko Saraste; Ann Kari Grindheim; Anni Vedeler
Journal:  FEBS Open Bio       Date:  2017-01-17       Impact factor: 2.693

10.  ANXC7 Is a Mitochondrion-Localized Annexin Involved in Controlling Conidium Development and Oxidative Resistance in the Thermophilic Fungus Thermomyces lanuginosus.

Authors:  Xiang-Li Xie; Huan Yang; Li-Na Chen; Yi Wei; Shi-Hong Zhang
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.